Tokyo, April 9 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061197) titled 'Long-term outcomes of half-dose photodynamic therapy for chronic central serous chorioretinopathy' on April 8.
Study Type:
Observational
Primary Sponsor:
Institute - Nagoya University
Condition:
Condition - Chronic central serous chorioretinopathy
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To clarify the long-term clinical course after half-dose photodynamic therapy in patients with chronic central serous chorioretinopathy and to consider appropriate treatment options for the future.
Basic objectives2 - Safety
Eligibility:
Age-lower limit - 20
years-old
=
Ge...